Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study TB Larsen, LH Rasmussen, F Skjøth, KM Due, T Callréus, M Rosenzweig, ... Journal of the American College of Cardiology 61 (22), 2264-2273, 2013 | 572 | 2013 |
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study TB Larsen, F Skjøth, PB Nielsen, JN Kjældgaard, GYH Lip bmj 353, 2016 | 526 | 2016 |
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation GYH Lip, TB Larsen, F Skjøth, LH Rasmussen Journal of the American College of Cardiology 60 (8), 738-746, 2012 | 413 | 2012 |
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study PB Nielsen, F Skjøth, M Søgaard, JN Kjældgaard, GYH Lip, TB Larsen bmj 356, 2017 | 388 | 2017 |
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care DA Lane, F Skjøth, GYH Lip, TB Larsen, D Kotecha Journal of the American Heart Association 6 (5), e005155, 2017 | 315 | 2017 |
Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide … PB Nielsen, TB Larsen, F Skjøth, A Gorst-Rasmussen, LH Rasmussen, ... Circulation 132 (6), 517-525, 2015 | 300 | 2015 |
Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc? PB Nielsen, F Skjøth, TF Overvad, TB Larsen, GYH Lip Circulation 137 (8), 832-840, 2018 | 218 | 2018 |
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score GYH Lip, F Skjøth, LH Rasmussen, TB Larsen Journal of the American College of Cardiology 65 (14), 1385-1394, 2015 | 217 | 2015 |
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study A Gorst‐Rasmussen, F Skjøth, TB Larsen, LH Rasmussen, GYH Lip, ... Journal of Thrombosis and Haemostasis 13 (4), 495-504, 2015 | 196 | 2015 |
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis LH Rasmussen, TB Larsen, T Graungaard, F Skjøth, GYH Lip Bmj 345, 2012 | 177 | 2012 |
Effects of varying content of soluble dietary fibre from wheat flour and oat milling fractions on gastric emptying in pigs HN Johansen, KEB Knudsen, B Sandström, F Skjøth British journal of nutrition 75 (3), 339-351, 1996 | 176 | 1996 |
Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study J Bodilsen, PB Nielsen, M Søgaard, M Dalager-Pedersen, LOZ Speiser, ... Bmj 373, 2021 | 163 | 2021 |
Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation TB Larsen, A Gorst-Rasmussen, LH Rasmussen, F Skjøth, M Rosenzweig, ... The American journal of medicine 127 (7), 650-656. e5, 2014 | 151 | 2014 |
Body mass index and adverse events in patients with incident atrial fibrillation TF Overvad, LH Rasmussen, F Skjøth, K Overvad, GYH Lip, TB Larsen The American journal of medicine 126 (7), 640. e9-640. e17, 2013 | 142 | 2013 |
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation F Skjøth, TB Larsen, LH Rasmussen, GYH Lip Thrombosis and haemostasis 112 (05), 981-988, 2014 | 128 | 2014 |
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score GYH Lip, F Skjøth, PB Nielsen, TB Larsen Thrombosis and haemostasis 114 (10), 826-834, 2015 | 125 | 2015 |
Quantifying and characterizing behavior in dairy calves using the IceTag automatic recording device P Trénel, MB Jensen, EL Decker, F Skjøth Journal of dairy science 92 (7), 3397-3401, 2009 | 118 | 2009 |
Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study TF Overvad, F Skjøth, GYH Lip, DA Lane, IE Albertsen, LH Rasmussen, ... Stroke 46 (8), 2168-2174, 2015 | 112 | 2015 |
Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: a nationwide cohort study PB Nielsen, TB Larsen, F Skjøth, TF Overvad, GYH Lip Scientific reports 6 (1), 27410, 2016 | 102 | 2016 |
Myocardial ischemic events in ‘real world’patients with atrial fibrillation treated with dabigatran or warfarin TB Larsen, LH Rasmussen, A Gorst-Rasmussen, F Skjøth, M Rosenzweig, ... The American journal of medicine 127 (4), 329-336. e4, 2014 | 99 | 2014 |